Titre : | Regulatory toxicology and pharmacology, vol. 35, n° 2. - 2002 |
Type de document : | Bulletin |
Paru le : | 01/01/2002 |
Dépouillements
Ajouter le résultat à ma sélectionArticle
OTTER (Willem-Den) : NLD. Department of Cell Biology and Histology. Utrecht University. TD Utrecht. ;
Peter-A STEERENBERG ;
Jan-Willem VAN DER LAAN ;
Laboratory of Pathology and Immunobiology. National Institute for Public Health and the Environment. BA Bilthoven. NLD ;
Preclinical Assessment Group of the Medicines Evaluation Board in the Netherlands. Laboratory for Medicines and Medical Devices. National Institute for Public Health and the Environment. BA Bilthoven. NLD
|
[BDSP. Notice produite par INIST-CNRS j9UR0xyb. Diffusion soumise à autorisation]. Regulatory authorities for medicines in European countries deal with many applications for admission to the market of anticancer drugs. Each application must be s[...]
Article
Janice-M FIORI ;
Roger-D MEYERHOFF ;
Toxicology and Drug Disposition. Lilly Research Laboratories. A Division of Eli Lilly and Company. Greenfield. IN. USA
|
[BDSP. Notice produite par INIST-CNRS sziJR0x3. Diffusion soumise à autorisation]. Risk assessment processes for carcinogens are highly developed but risk assessment processes for mutagens are not well established. In the pharmaceutical industry[...]